Human Genome Epidemiology Literature Finder
|
Records 1 - 21 (of 21 Records) |
| Query Trace: Carcinoma and CYP1A2[original query] |
|---|
| Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2. Pharmacogenetics 2001 Jul 11 (5): 429-35. Han XM, Ou-Yang DS, Lu PX, Jiang CH, Shu Y, Chen XP, Tan ZR, Zhou HH |
| CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. International journal of cancer. Journal international du cancer 2003 Apr 104 (3): 310-7. Silvestri Laura, Sonzogni Laura, De Silvestri Annalisa, Gritti Chiara, Foti Luciana, Zavaglia Claudio, Leveri Michela, Cividini Agostino, Mondelli Mario U, Civardi Emilio, Silini Enrico |
| Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. Journal of cancer research and clinical oncology 2004 Feb 130 (2): 99-106. Tsukino Hiromasa, Kuroda Yoshiki, Nakao Hiroyuki, Imai Hirohisa, Inatomi Hisato, Osada Yukio, Katoh Takahi |
| Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Sep 14 (9): 2183-90. Starr Jacqueline R, Chen Chu, Doody David R, Hsu Li, Ricks Sherianne, Weiss Noel S, Schwartz Stephen |
| Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma. Journal of gastroenterology and hepatology 2005 Aug 20 (8): 1191-7. Mochizuki J, Murakami S, Sanjo A, Takagi I, Akizuki S, Ohnishi A |
| Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China. Pharmacogenetics and genomics 2006 Mar 16 (3): 219-27. Chen Xiaoping, Wang Haijian, Xie Weimin, Liang Renxiang, Wei Zhongliang, Zhi Lianteng, Zhang Xiumei, Hao Bingtao, Zhong Shaofei, Zhou Gangqiao, Zhang Lingqiang, Gao Xue, Zhu Yunping, He Fuc |
| Interaction between CYP1A2-T2467DELT polymorphism and smoking in adenocarcinoma and squamous cell carcinoma of the lung. Lung cancer (Amsterdam, Netherlands) 2007 Sep 57 (3): 266-72. Pavanello Sofia, B'chir Fatma, Pulliero Alessandra, Saguem Saâd, Ben Fraj Radhia, El Aziz Hayouni Abed, Clonfero Erminio, Mastrangelo Giusep |
| Coffee consumption, genetic susceptibility and bladder cancer risk. Cancer causes & control : CCC 2009 Feb 20 (1): 121-7. Villanueva Cristina M, Silverman Debra T, Murta-Nascimento Cristiane, Malats Núria, Garcia-Closas Montserrat, Castro Francesc, Tardon Adonina, Garcia-Closas Reina, Serra Consol, Carrato Alfredo, Rothman Nathaniel, Real Francisco X, Dosemeci Mustafa, Kogevinas Manol |
| Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population. Carcinogenesis 2009 Oct 30 (10): 1729-34. Imaizumi Takeshi, Higaki Yasuki, Hara Megumi, Sakamoto Tatsuhiko, Horita Mikako, Mizuta Toshihiko, Eguchi Yuichiro, Yasutake Tsutomu, Ozaki Iwata, Yamamoto Kyosuke, Onohara Shingo, Kawazoe Seiji, Shigematsu Hirohisa, Koizumi Shunzo, Kudo Sho, Tanaka Keita |
| CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients. Oral oncology 2009 Sep 45 (9): e73-9. Olivieri Eloisa Helena Ribeiro, da Silva Sabrina Daniela, Mendonça Fernando Fernandes, Urata Yuri Nagamine, Vidal Daniel Onofre, Faria Marcilia de Araujo Medrado, Nishimoto Inês Nobuko, Rainho Claudia Aparecida, Kowalski Luiz Paulo, Rogatto Silvia Regi |
| CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population. Life sciences 2009 May 84 (21-22): 779-84. B'chir Fatma, Pavanello Sofia, Knani Jalel, Boughattas Sami, Arnaud Maurice J, Saguem Sa |
| Polymorphism in cytochrome P450 1A2 and their interaction with risk factors in determining risk of squamous cell lung carcinoma in men. Cancer biomarkers : section A of Disease markers 2011 11 8 (6): 351-9. Singh Arvind P, Pant Mohan C, Ruwali Munindra, Shah Parag P, Prasad Rajendra, Mathur Neeraj, Parmar Devend |
| Meta-analysis of the CYP1A2 -163C>A polymorphism and lung cancer risk. Asian Pacific journal of cancer prevention : APJCP 2013 14 (5): 3155-8. Deng Sheng-Qiong, Zeng Xian-Tao, Wang Yun, Ke Qing, Xu Qiong- |
| Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk. Clinical endocrinology 2012 Dec . Barbieri R, Bufalo N, Cunha L, Assumpção L, Maciel R, Cerutti J, Ward L |
| Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma. Oncotarget 2016 May . Zhou Jun, Wen Qiang, Li Sai-Fei, Zhang Yun-Fei, Gao Na, Tian Xin, Fang Yan, Gao Jie, Cui Ming-Zhu, He Xiao-Pei, Jia Lin-Jing, Jin Han, Qiao Hai-Li |
| Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype. Human genomics 2016 Nov 10 (1): 39. Jorge-Nebert Lucia F, Zhang Ge, Wilson Keith M, Jiang Zhengwen, Butler Randall, Gluckman Jack L, Pinney Susan M, Nebert Daniel |
| The associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China. Oncotarget 2017 Mar . Bai Xianan, Xie Jingjing, Sun Shanshan, Zhang Xianyu, Jiang Yongdong, Pang |
| CYP1A2*1F Gene Variant, Alkaline Salt Tea Intake and Risk of Esophageal Squamous Cell Carcinoma. Nutrition and cancer 2017 Dec 1-7. Shah Idrees Ayoub, Mehta Promila, Lone M Maqbool, Rasool Malik Tariq, Lone Ghulam Nabi, Gulzar G M, Ganie Farooq Ahmad, Bhat Mohmmad Akbar, Dar Nazir Ahm |
| The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral oncology 2019 Sep 98 48-52. De Marchi Pedro, Melendez Matias E, Laus Ana C, Kuhlmann Pamela A, de Carvalho Ana Carolina, Arantes Lidia Maria R B, Evangelista Adriane F, Andrade Edilene S, de Castro Gilberto, Reis Rui M, Carvalho André Lopes, de Souza Viana Lucia |
| The ovarian carcinoma risk with the polymorphisms of CYP1B1 come from the positive selection. American journal of translational research 2021 13 (5): 4322-4341. Zhang Liying, Feng Liyuan, Lou Meng, Deng Xihan, Liu Chuanzhong, Li |
| Unraveling the molecular significance of CYP1A2 (rs762551; c.-9-154?C>A) genetic variant on breast carcinoma susceptibility: Insights from case-control study and meta-analysis. Pathology, research and practice 2024 8 261 155501. Adel I Alalawy, Mohamed I Sakran, Fahad M Alzuaibr, Maeidh A Alotaibi, Rami M Elshaz |
- Page last reviewed:Feb 1, 2024
- Content source: